EU approves sale of new Alzheimer's drug, with conditions

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer's disease, to be sold in the EU under strict conditions.
đ Full Story

Chaos ERUPTS after Woman is FIRED first day with New Supervisor
- New Law in England Requires Cat Microchipping or Face ÂŁ500 Fines - Bertha Stephens
- Regulating AI-generated Voices: The FCC's Stand Against Misleading Robocalls - Sean George
- Googleâs Gemini 2.5 Flash introduces âthinking budgetsâ that cut AI costs by 600% when turned down - Michael Nuñez
- Understanding the Rabbit R1: A Revolution in the World of AI - Sean George
- White House Converts Its COVID Website Into Dossier of Pandemic Crimes â Exposes Fauci, Lab Leak, Lockdowns, Mask Mandates and Industrial Censorship - MeighTimbol
- Goody-2 is an AI-powered chatbot that is designed to push boundaries when it comes to safety and responsibility. - Sean George

Android Fanboy Tries the Most Hated iPhone!
- Can Allergies Cause Bronchitis: Symptoms, Treatments, and Insights - Lindsay Curtis
- The Hidden Consequences of Melting Arctic Ice - Arya Chandran
- Suze Ormanâs Straightforward Advice on Maximizing Social Security Benefits - Zoul
- Understanding Formaldehyde: A Carcinogen with a Dual Role in the Body - Arya Chandran
- âRansom Canyonâ Star Minka Kelly Talks Netflixâs Response To Pay Parity Request - Nellie Andreeva
- Chromeâs new dynamic bottom bar gives websites a little more room to breathe - Ryan Whitwam